This can be achieved by using [F7, P34]-NPY, a NPY1R-preferring peptide ligand, which was already successfully used to target NPY1R-positive breast cancer cells [[61], [62], [63],66,79,80]. The gene discussed is NPY; the disease is breast carcinoma.